You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 1, January 2, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •World Health
 •Public Health, Other
 •Law and Medicine
 •Medical Practice, Other
 •Pain
 •Alert me on articles by topic

Ensuring Effective Pain Treatment

A National and Global Perspective

Allyn L. Taylor, JD, LLM, JSD; Lawrence O. Gostin, JD; Katrina A. Pagonis, JD, MPH, LLM

JAMA. 2008;299(1):89-91.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Medical availability of effective pain medication is vitally important domestically and globally. Medical advances have substantially improved the technical capacity to control pain and diminish its consequences. Worldwide, millions of persons with chronic, acute, and terminal conditions have found relief from excruciating pain through medical intervention. However, richer countries have disproportionately benefited from improvements in access to and use of pain medication. The tragedy is that for most of the world's population, particularly persons in poorer countries, effective pain control is entirely unavailable.

An estimated 80% of persons worldwide do not receive adequate treatment for pain, and severe undertreatment for pain is an acute problem in more than 150 countries.1 Hospice and palliative care services exist or are being developed in about 100 countries, but their global distribution is uneven. Although the majority of . . . [Full Text of this Article]

Attitudinal Barriers

Author Affiliations: O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC.


RELATED ARTICLE

Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency Departments
Mark J. Pletcher, Stefan G. Kertesz, Michael A. Kohn, and Ralph Gonzales
JAMA. 2008;299(1):70-78.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.